Is stem cell-based therapy going on or out for cardiac disease?

Korean Circulation Journal

Volumn 39, Issue 3, 2009, Pages 87-92

  Byun, Ki Hyun ^a,b   Kim, Sung Whan ^b  

^a Kwandong University College of Medicine   (South Korea)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyocytes; Cell differentiation; Regeneration; Stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ACUTE HEART INFARCTION; ADULT STEM CELL; ANGIOGENESIS; CAUSE OF DEATH; CELL DIFFERENTIATION; CELL REGENERATION; CELL TYPE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DRUG ELUTING STENT; EMBRYONIC STEM CELL; FETAL STEM CELL; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART PERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMATOPOIETIC STEM CELL; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; PLURIPOTENT STEM CELL; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEM CELL TRANSPLANTATION;

EID: 63649114157     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2009.39.3.87     Document Type: Review

References (30)

1. Passier R, van Laake LW, Mummery CL. Stem-cell-based therapy and lessons from the heart Nature 2008;453:322-9.
2. Joficoeur EM, Granger CB, Fakunding JL, et al. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am Heart J 2007;153:732-42.
3. Beltrami AP, Urbanek K, Anversa P, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-7.
4. Quaini F, Urbanek K, Anversa P, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15.
5. Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 1999;9:10711-6.
6. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001;107:1395-402.
7. Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell 2008;132:537-43.
8. Yuasa S, Itabashi Y, Koshimizu U, et al. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 2005;23:607-11.
9. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282: 1145-7.
10. Orlic D, Kajstura J, Anversa P, et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701-5.
11. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.
12. Schächinger V, Erbs S, Elsässer A, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-21.
13. Assmus B, Honold J, Schächinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32.
14. Adler ED, Maddox TM. Cell therapy for cardiac disease: where do we go from here? Nat Clin Pract Cardiovasc Med 2007;4:2-3.
15. Lunde K, Solheim S, Aakhus S, et al. Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction. Am Heart J 2007;154:710, e1-8.
16. Murry CE, Soonpaa MH, Reinecke H, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-8.
17. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature hoematopoietic fates in ischaemic myocardium. Nature 2004;428:668-73.
18. Nygren JM, Jovinge S, Breitbach M, et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004; 10:494-501.
19. Schächinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Pract Cardiovasc Med 2006;3 (Suppl 1):S23-8.
20. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-97.
21. Messina E, De Angelis L, Giacomello A, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911-21.
22. Bearzi C, Rota M, Anversa P, et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 2007;104:14068-73.
23. Hudon-David F, Bouzeghrane F, Couture P, Thibault G. Thy-1 expression by cardiac fibroblasts: lack of association with myofibroblast contractile markers. J Mol Cell Cardiol 2007;42:991-1000.
24. Smart N, Risebro CA, Melville AA, et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007;445:177-82.
25. Lepilina A, Coon AN, Poss KD, et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006;127:607-19.
26. Lepilina A, Coon AN, Kikuchi K, et al. A dynamic epicardial injury response supports progenitor cell activity during zebrafish heart regeneration. Cell 2006;127:607-19.
27. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008;451:937-42.
28. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76.
29. Yu J, Vodyanik MA, Thomson JA, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-20.
30. Hanna J, Wernig M, Jaenisch R, et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920-3.